University of California San Francisco
Helen Diller Family Comprehensive Cancer Center
Erin Van Blarigan, ScD

Erin Van Blarigan, ScD

Assistant Professor, Departments of Epidemiology and Biostatistics, and Urology, UC, San Francisco

Cancer Center Program Memberships

Prostate Cancer | Cancer Control

Education

University of California, Davis, BS 2007 Biological Science
Harvard School of Public Health, ScM 2009 Epidemiology
Harvard School of Public Health, ScD 2011 Epidemiology, Nutrition (double major)
University of California, San Francisco, 2011-2013, Epidemiology and Biostatistics (Division of Cancer Epidemiology, post-doctoral scholar)


Professional Experience

  • 2008
    Research Assistant, Department of Urology, School of Medicine, University of California, San Francisco
  • 2009-10
    Teaching Assistant, Departments of Epidemiology and Nutrition, Harvard School of Public Health
  • 2010-11
    Assistant Specialist, Department of Urology, School of Medicine, University of California, San Francisco
  • 2011
    Research Assistant, Department of Epidemiology and Biostatistics, University of California, San Francisco
  • 2011-2013
    Post-doctoral Scholar, Division of Cancer Epidemiology, Department of Epidemiology and Biostatistics, University of California, San Francisco, NIH Training Program in Genetic and Molecular Epidemiology of Cancer
  • 2014-present
    Assistant Professor, Department of Epidemiology and Biostatistics, and Urology, University of California, San Francisco

Honors & Awards

  • 2003-07
    Regents' Scholar, University of California, Davis
  • 2009 Distinction on Methods and Substantive Areas of Epidemiology Doctoral Qualifying Exam,
    Department of Epidemiology, Harvard School of Public Health
  • 2010
    Best Population Science/Outcomes Research Poster, Prostate Cancer Program Scientific
    Research Retreat, University of California, San Francisco
  • 2010
    Campbell Scholar, American Institute of Cancer Research Annual Research Conference,
    Washington D.C.
  • 2011
    Honorable Mention, Third North American Congress of Epidemiology Lilienfeld Student Paper
    Prize Award
  • 2012
    Conquer Cancer Foundation Merit Award, American Society of Clinical Oncology
    Genitourinary Cancer Symposium, San Francisco, CA

Selected Publications

  1. Emami NC, Leong L, Wan E, Van Blarigan EL, Cooperberg MR, Tenggara I, Carroll PR, Chan JM, Witte JS, Simko JP. Tissue Sources for Accurate Measurement of Germline DNA Genotypes in Prostate Cancer Patients Treated With Radical Prostatectomy. Prostate. 2016 Nov 30.
    View on PubMed
  2. Peisch SF, Van Blarigan EL, Chan JM, Stampfer MJ, Kenfield SA. Prostate cancer progression and mortality: a review of diet and lifestyle factors. World J Urol. 2016 Aug 12.
    View on PubMed
  3. Downer MK, Van Blarigan EL, Peisch SF, Stampfer MJ. Should We Fear Folate? Eur Urol. 2016 Dec; 70(6):952-953.
    View on PubMed
  4. Nordström T, Van Blarigan EL, Ngo V, Roy R, Weinberg V, Song X, Simko J, Carroll PR, Chan JM, Paris PL. Associations between circulating carotenoids, genomic instability and the risk of high-grade prostate cancer. Prostate. 2016 Mar; 76(4):339-48.
    View on PubMed
  5. Kenfield SA, Batista JL, Jahn JL, Downer MK, Van Blarigan EL, Sesso HD, Giovannucci EL, Stampfer MJ, Chan JM. Development and Application of a Lifestyle Score for Prevention of Lethal Prostate Cancer. J Natl Cancer Inst. 2016 Mar; 108(3).
    View on PubMed
  6. Van Blarigan EL, Kenfield SA, Yang M, Sesso HD, Ma J, Stampfer MJ, Chan JM, Chavarro JE. Fat intake after prostate cancer diagnosis and mortality in the Physicians' Health Study. Cancer Causes Control. 2015 Aug; 26(8):1117-26.
    View on PubMed
  7. Yang M, Kenfield SA, Van Blarigan EL, Wilson KM, Batista JL, Sesso HD, Ma J, Stampfer MJ, Chavarro JE. Dairy intake after prostate cancer diagnosis in relation to disease-specific and total mortality. Int J Cancer. 2015 Nov 15; 137(10):2462-9.
    View on PubMed
  8. Yang M, Kenfield SA, Van Blarigan EL, Batista JL, Sesso HD, Ma J, Stampfer MJ, Chavarro JE. Dietary patterns after prostate cancer diagnosis in relation to disease-specific and total mortality. Cancer Prev Res (Phila). 2015 Jun; 8(6):545-51.
    View on PubMed
  9. Joshu CE, Peskoe SB, Heaphy CM, Kenfield SA, Van Blarigan EL, Mucci LA, Giovannucci EL, Stampfer MJ, Yoon G, Lee TK, Hicks JL, De Marzo AM, Meeker AK, Platz EA. Prediagnostic Obesity and Physical Inactivity Are Associated with Shorter Telomere Length in Prostate Stromal Cells. Cancer Prev Res (Phila). 2015 Aug; 8(8):737-42.
    View on PubMed
  10. Van Blarigan EL, Meyerhardt JA. Role of physical activity and diet after colorectal cancer diagnosis. J Clin Oncol. 2015 Jun 1; 33(16):1825-34.
    View on PubMed
  11. Helfand BT, Roehl KA, Cooper PR, McGuire BB, Fitzgerald LM, Cancel-Tassin G, Cornu JN, Bauer S, Van Blarigan EL, Chen X, Duggan D, Ostrander EA, Gwo-Shu M, Zhang ZF, Chang SC, Jeong S, Fontham ET, Smith G, Mohler JL, Berndt SI, McDonnell SK, Kittles R, Rybicki BA, Freedman M, Kantoff PW, Pomerantz M, Breyer JP, Smith JR, Rebbeck TR, Mercola D, Isaacs WB, Wiklund F, Cussenot O, Thibodeau SN, Schaid DJ, Cannon-Albright L, Cooney KA, Chanock SJ, Stanford JL, Chan JM, Witte J, Xu J, Bensen JT, Taylor JA, Catalona WJ. Associations of prostate cancer risk variants with disease aggressiveness: results of the NCI-SPORE Genetics Working Group analysis of 18,343 cases. Hum Genet. 2015 Apr; 134(4):439-50.
    View on PubMed
  12. Kenfield SA, Van Blarigan EL, DuPre N, Stampfer MJ, L Giovannucci E, Chan JM. Selenium supplementation and prostate cancer mortality. J Natl Cancer Inst. 2015 Jan; 107(1):360.
    View on PubMed
  13. Gerstenberger JP, Bauer SR, Van Blarigan EL, Sosa E, Song X, Witte JS, Carroll PR, Chan JM. Selenoprotein and antioxidant genes and the risk of high-grade prostate cancer and prostate cancer recurrence. Prostate. 2015 Jan; 75(1):60-9.
    View on PubMed
  14. Chan JM, Van Blarigan EL, Kenfield SA. What should we tell prostate cancer patients about (secondary) prevention? Curr Opin Urol. 2014 May; 24(3):318-23.
    View on PubMed
  15. Van Blarigan EL, Ma J, Kenfield SA, Stampfer MJ, Sesso HD, Giovannucci EL, Witte JS, Erdman JW, Chan JM, Penney KL. Plasma antioxidants, genetic variation in SOD2, CAT, GPX1, GPX4, and prostate cancer survival. Cancer Epidemiol Biomarkers Prev. 2014 Jun; 23(6):1037-46.
    View on PubMed
  16. Tomaszewski JJ, Richman EL, Sadetsky N, O'Keefe DS, Carroll PR, Davies BJ, Chan JM. Impact of folate intake on prostate cancer recurrence following definitive therapy: data from CaPSURE™. J Urol. 2014 Apr; 191(4):971-6.
    View on PubMed
  17. Bauer SR, Richman EL, Sosa E, Weinberg V, Song X, Witte JS, Carroll PR, Chan JM. Antioxidant and vitamin E transport genes and risk of high-grade prostate cancer and prostate cancer recurrence. Prostate. 2013 Dec; 73(16):1786-95.
    View on PubMed
  18. Kenfield SA, DuPre N, Richman EL, Stampfer MJ, Chan JM, Giovannucci EL. Mediterranean diet and prostate cancer risk and mortality in the Health Professionals Follow-up Study. Eur Urol. 2014 May; 65(5):887-94.
    View on PubMed
  19. Richman EL, Kenfield SA, Chavarro JE, Stampfer MJ, Giovannucci EL, Willett WC, Chan JM. Fat intake after diagnosis and risk of lethal prostate cancer and all-cause mortality. JAMA Intern Med. 2013 Jul 22; 173(14):1318-26.
    View on PubMed
  20. Richman EL, Kenfield SA, Stampfer MJ, Giovannucci EL, Zeisel SH, Willett WC, Chan JM. Choline intake and risk of lethal prostate cancer: incidence and survival. Am J Clin Nutr. 2012 Oct; 96(4):855-63.
    View on PubMed

Go to UCSF Profiles, powered by CTSI